PLoS ONE
(Jan 2024)
Differential laboratory passaging of SARS-CoV-2 viral stocks impacts the in vitro assessment of neutralizing antibodies
- Aram Avila-Herrera,
- Jeffrey A. Kimbrel,
- Jose Manuel Martí,
- James Thissen,
- Edwin A. Saada,
- Tracy Weisenberger,
- Kathryn T. Arrildt,
- Brent W. Segelke,
- Jonathan E. Allen,
- Adam Zemla,
- Monica K. Borucki
Affiliations
- Aram Avila-Herrera
- Jeffrey A. Kimbrel
- Jose Manuel Martí
- James Thissen
- Edwin A. Saada
- Tracy Weisenberger
- Kathryn T. Arrildt
- Brent W. Segelke
- Jonathan E. Allen
- Adam Zemla
- Monica K. Borucki
- Journal volume & issue
-
Vol. 19,
no. 1
WeChat QR code